September 29, 2026 at 08:07 PM UTC
Larimar Therapeutics, Inc. reports leadership or board changes
Larimar Therapeutics, Inc. filed an 8-K covering director or executive-officer changes. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 29, 2026 at 08:06 PM UTC
Open official source